Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | HTR3A | P46098 | 7/20 | 0.32 |
| ▸ | HTR3E | A5X5Y0 | 6/20 | 0.32 |
| ▸ | HTR3B | O95264 | 6/20 | 0.32 |
| ▸ | HTR3D | Q70Z44 | 6/20 | 0.32 |
| ▸ | HTR3C | Q8WXA8 | 6/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9406216 | 0.81 | SCN1A (0.33) | NAAAHTR3A | |
| SCHEMBL9406213 | 0.81 | SCN1A (0.33) | NAAAHTR3A | |
| SCHEMBL9457296 | 0.81 | NAAA (0.38) | NAAA | |
| SCHEMBL9457291 | 0.81 | NAAA (0.38) | NAAA | |
| SCHEMBL9457323 | 0.81 | SCN1A (0.33) | NAAAHTR3A | |
| SCHEMBL9457310 | 0.81 | SCN1A (0.33) | NAAAHTR3A | |
| SCHEMBL13025795 | 0.81 | NAAA (0.35) | NAAAHTR3AHTR3EHTR3BHTR3D | |
| SCHEMBL9406315 | 0.81 | NAAA (0.37) | NAAAHTR3AHTR3EHTR3BHTR3D | |
| SCHEMBL9406319 | 0.81 | NAAA (0.37) | NAAAHTR3AHTR3EHTR3BHTR3D | |
| SCHEMBL13025810 | 0.80 | NAAA (0.33) | NAAAHTR3AHTR3EHTR3BHTR3D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7838087-B2 | Benzene derivative, liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-11-23 | — | — | US | disclosed |
| US-20070200092-A1 | Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device | JNC PETROCHEMICAL CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070200092-A1 | Benzene Derivative, Liquid Crystal Composition And Liquid Crystal Display Device | CCND2, YBX1, CNKSR1 | NAAA 4164/4885HTR3A 4329/4885HTR3E 4286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.